University Hospitals Cleveland Medical Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, University Hospitals Cleveland Medical Center sits in the top decile of US sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count).
University Hospitals Cleveland Medical Center: 230 sponsored US clinical trials, 42 recruiting.
University Hospitals Cleveland Medical Center sponsors 230 registered US clinical trials on ClinicalTrials.gov, 42 of them currently recruiting, and 154 completed. 48 of these trials are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.
Top-decile sponsor footprint
University Hospitals Cleveland Medical Center ranks in the top decile of sponsors by registered trial count (#142 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
154 of 181 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
230 total, page 4 of 5
Surgical Theater's Surgery Rehearsal Platform
NCT02099318
Optical Imaging Measurement of Intravascular Solution Efficacy Trial
NCT01743872
Pioglitazone for the Treatment of Bipolar Depression
NCT01717040
Evaluation of a TAP Block Given During Laparoscopic Colorectal Surgery to Help Control Pain
NCT01731782
Evaluation of a Novel Endoscopic Treatment for Achalasia
NCT01770249
Open Label Study of Isotretinoin in Mild to Moderate Alzheimer's Disease
NCT01560585
Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
NCT01845441
Gao Bipolar Spectrum Lithium/Quetiapine Study
NCT01526148
Vitamin D Supplementation in HIV Youth
NCT01523496
Asenapine in the Treatment of Older Adults With Bipolar Disorder
NCT01460290
Vitamin D and HIV-Cardiovascular Disease in Children and Young Adults
NCT01410305
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
NCT01459666
Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers
NCT01272661
Life 4°C Versus Optisol in Corneal Storage Media
NCT01657500
Electrical and Formocresol Pulpotomy in Primary Molars
NCT01622153
Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation
NCT01315665
Microarray Analysis of Scalp Biopsies After Minoxidil Treatment
NCT01309191
Pioglitazone and Quetiapine XR Pharmacogenetic Study
NCT01342380
Apollo Overstitch, a Treat and Resect Model
NCT01307813
Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
NCT01218802
Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection System
NCT01322737
Ziprasidone Switching in Response to Adherence and Psychotropic-Related Weight Gain Concerns Among Patients With Bipolar Disorder (Zip Ad)
NCT01293825
Comparative Study of Biologic Mesh Versus Repair With Component Separation.
NCT01295125
Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube
NCT01263873
QI Study of a Practice Facilitator's Impact in Working With Clinics on Improving Dental, Lead & Obesity Measures for Children
NCT01739166
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
NCT01152697
Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes
NCT01083433
Assessing Infectious Risk and Visceral Closure in Natural Orifice Translumenal Endoscopic Surgery (NOTES)
NCT01102725
Intrapartum Epidural Fentanyl/Bupivacaine Analgesia, Infant Feeding Behavior, & Breast-Feeding Outcomes
NCT01260051
Ambulatory Blood Pressure Monitoring in Children
NCT01070342
Pilot Study Evaluating the Efficacy of AlloMEM After Loop Ileostomy
NCT01113736
Study of Vitamin D and Effect on Heart Disease and Insulin Resistance
NCT01093417
Daily Wear Corneal Infiltrative Event Study
NCT00937105
Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills
NCT01119027
Cognitive Function in Adults With Cardiac Disease
NCT01043315
Cataract Removal and Alzheimer's Disease
NCT00921297
Pilot Placebo Controlled Study With Lovaza in Cardiovascular Disease
NCT01001767
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance
NCT00835120
Customized Medication Adherence Enhancement for Adults With Bipolar Disorder
NCT00830310
Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults
NCT01046682
Breath-Actuated Nebulizer Versus Conventional Continuous-Output Nebulizer in Pediatric Asthma Patients
NCT01045174
Feeding and Wellness Among Late Preterm Infants
NCT00470717
Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease
NCT00791557
Safety and Efficacy of CC-10004 for Prurigo Nodularis
NCT00869089
Treatment of Hemorrhagic Radiation Proctitis Using the Halo System
NCT01103492
Study of a New Circular Anal Dilator
NCT00693459
Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
NCT00671853
Lamotrigine for Symptoms of Geriatric Bipolar Depression
NCT00621842
Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis
NCT00573651
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
NCT00575939
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 13 |
| Phase 3 | 16 |
| Phase 4 | 32 |
Where University Hospitals Cleveland Medical Center enrollment is open (later-stage tilt)
42 recruiting of 230 indexed (18% open); 154 completed (67%).
Phase mix: 48 late (III/IV) vs 27 early (I/II) (later-stage heavy).
Top condition: Bipolar Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University Hospitals Cleveland Medical Center: open-pipeline peers nationwide
Peers matched on 230 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University Hospitals Cleveland Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 230 trials (± recruiting share)
- Brown University · 231 trials · 15% recruiting
- University of Iowa · 228 trials · 12% recruiting
- Georgetown University · 227 trials · 15% recruiting
- Henry Ford Health System · 234 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Burke Medical Research Institute · 18% recruiting · 11 trials
- Grand Valley State University · 18% recruiting · 11 trials
- Imunon · 18% recruiting · 11 trials
- InventisBio Co. · 18% recruiting · 11 trials
Related
What to do with this University Hospitals Cleveland Medical Center page
230 registered trials is a research-attention snapshot, not an endorsement of University Hospitals Cleveland Medical Center or any single study.
- 42 of University Hospitals Cleveland Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bipolar Disorder is the condition University Hospitals Cleveland Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University Hospitals Cleveland Medical Center pipeline card: 230 registered trials from official public datasets.Report a data error.